Litigation Details for Pfizer Inc. v. Tiger Pharmaceuticals, LLC (E.D. Va. 2014)
✉ Email this page to a colleague
Pfizer Inc. v. Tiger Pharmaceuticals, LLC (E.D. Va. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-11-09 |
| Court | District Court, E.D. Virginia | Date Terminated | 2015-02-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Anthony John Trenga |
| Jury Demand | None | Referred To | Thomas Rawles Jones Jr. |
| Patents | 6,124,363 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Tiger Pharmaceuticals, LLC
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Pfizer Inc. v. Tiger Pharmaceuticals, LLC (E.D. Va. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-11-09 | 1 | Complaint | interest in United States Patent No. 6,124,363 (the "'363 patent"), and the right to sue…Pfizer against Defendant for patent infringement of the '363 patent arising from Defendant's…BACKGROUND The *363 Patent 11. On September 26,2000, the United States Patent and Trademark Office…x27;363 patent, titled "Dofetilide Polymorphs." 12. The '363 patent discloses… Infringes the '363 Patent (Patent Infringement) 19 | External link to document |
| 2014-11-09 | 4 | Report Regarding Patent & Trademark | determination of an action regarding patent and/or trademark(s) 6,124,363.. (dvanm, ) (Entered: 11/12/2014… 23 February 2015 1:14-cv-01501 830 Patent None District Court, E.D. Virginia | External link to document |
| 2015-02-03 | 44 | Declaration of Craig Eckhardt, Ph.D. | recited in the claims of U.S. Patent No. 6,124,363 (“the ‘363 patent”) (attached hereto as Ex. 1). …at 1838.) IV. U.S. PATENT NO. 6,124,363 32. The ‘363 patent acknowledges much of what…............... 8 IV. U.S. PATENT NO. 6,124,363 ........................................…The ‘363 patent is directed to specific polymorphs of the drug dofetilide. The ‘363 patent explains…understand that there is one patent at issue in this litigation, the ‘363 patent. 42. For the | External link to document |
| 2015-02-03 | 46 | Claim Construction Brief | disputed claim terms of Pfizer’s U.S. Patent No. 6,124,363 (the “’363 patent”) (Ex. A)1 as identified in the…It is a ‘bedrock principle’ of patent law that ‘the claims of a patent define the invention to which … BACKGROUND This is a patent infringement case brought by Pfizer against Tiger…Act alleging that Tiger has infringed the ’363 patent by filing an Abbreviated New Drug Application with… product prior to the expiration of the ’363 patent. Pfizer’s Tikosyn capsules are approved by the | External link to document |
| 2015-02-17 | 50 | Supplemental Affidavit of Jason T. Murata | excerpt from the prosecution history of U.S. Patent No. 6,124,363, namely the patentee's Response After… 23 February 2015 1:14-cv-01501 830 Patent None District Court, E.D. Virginia | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
